Cancer Research UK Cambridge Research Institute, Room 215
Contact: No managers listed
0 upcoming talks View 12 archived talks
**CANCELLED** The role of EGFR family receptor signaling-induced NF-kB activation in human breast cancer
Mapping tumor heterogeneity and developmental trajectories using 40 markers at single cell resolution:
The ETS transcription factor ELF5 and breast cancer phenotype
Gene expression programs controlling ER-negative breast cancer phenotype
RNAi libraries for high throughput phenotyping and drug resistance screening in the African trypanosome
Novel risk biomarkers based on DNA repair for early detection and prevention of lung cancer.
Inferring mechanisms of gene regulation from patterns of evolutionary divergence
HER2 phosphorylation is maintained by a PKB negative feedback loop in response to anti-HER2 Herceptin in breast cancer
Evidence of non-random mutation rates suggests a risk management strategy for bacterial evolution
Accelerated substitution rates in non-coding sequence: Gene duplication, transcription factor binding site turnover and biased gene conversion.
Regulation of Alternative Splicing by Histone Modifications
Characterisation of structural variation in 24 breast cancer genomes using paired-end sequencing on the Illumina Genome Analyser
Please see above for contact details for this list.
![[Talks.cam]](/static/images/talkslogosmall.gif)

Debajit Biswas, Dana-Farber Cancer Institute and Harvard Medical School.
Wednesday 19 March 2014, 15:00-16:00